Clinical Trials in Oncology and Rare Diseases Europe 2026
Almac Clinical Technologies are delighted to be attending the Clinical Trials in Oncology and Rare Diseases Europe 2026 event, taking place on 1st & 2nd December, in Munich, Germany.
About CNS Summit 2026
Clinical Trials in Oncology & Rare Diseases Europe 2026 brings together clinical operations professionals working across oncology and rare disease trials to address key operational challenges and strengthen collaboration between sponsors and vendors.
The event combines expert presentations, panel discussions and interactive roundtables, providing practical insights, case studies and networking opportunities to help improve clinical trial strategy and operations.
For more information please visit the Clinical Trials in Oncology and Rare Diseases Europe website.
Our Team
Andreas Loeffler
Head of Business Development - EU & APAC
Andreas.Loeffler@almacgroup.com